Crestline Management’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Sell
755,736
-465,201
-38% -$1.83M 4.7% 2
2025
Q4
$4.97M Sell
1,220,937
-600,000
-33% -$2.69M 9.32% 2
2025
Q3
$6.46M Sell
1,820,937
-600,000
-25% -$2.17M 11.13% 2
2025
Q2
$6.61M Sell
2,420,937
-370,000
-13% -$763K 10.56% 2
2025
Q1
$4.69M Sell
2,790,937
-70,000
-2% -$196K 7.41% 2
2024
Q4
$4.66M Sell
2,860,937
-224,687
-7% -$670K 0.16% 149
2024
Q3
$12.8M Sell
3,085,624
-140,000
-4% -$735K 0.73% 24
2024
Q2
$17.6M Sell
3,225,624
-140,000
-4% -$1.12M 1.38% 8
2024
Q1
$33.7M Hold
3,365,624
3.19% 3
2023
Q4
$13.7M Hold
3,365,624
1.27% 15
2023
Q3
$13M Hold
3,365,624
1.56% 8
2023
Q2
$20.1M Buy
3,365,624
+154,687
+5% +$891K 2.18% 3
2023
Q1
$10.5M Sell
3,210,937
-154,687
-5% -$618K 1.28% 15
2022
Q4
$13.3M Hold
3,365,624
1.95% 4
2022
Q3
$20.2M Hold
3,365,624
2.73% 2
2022
Q2
$21.6M Buy
3,365,624
+154,687
+5% +$985K 2.84% 2
2022
Q1
$26.5M Hold
3,210,937
3.33% 2
2021
Q4
$49.7M Hold
3,210,937
3.73% 6
2021
Q3
$72.3M Hold
3,210,937
6.88% 2
2021
Q2
$63.1M Buy
+3,210,937
New +$72.8M 5.46% 2

Other funds holding SANA